Topic: Reuters Group plc
NEW YORK (Reuters Health) - One New Orleans hospital saw a jump in heart attacks following Hurricane Katrina -- and three years later, the rate was still elevated, a new study finds.Researchers at Tulane University Hospital found that over the three years ...
ADELPHI, Maryland (Reuters) - U.S. drug advisers recommended that the label for Johnson and Johnson's Ortho Evra birth control patch be simplified to better explain the risk of blood clots.In a 20 to 3 vote with one abstention, advisers to the Food ...
ADELPHI, Maryland (Reuters) - U.S. health advisers recommended a revision of labels for the widely used new generation of birth control pills, based on data showing they may put women at a higher risk of dangerous blood clots.Although all common birth control ...
WASHINGTON (Reuters) - A U.S. Food and Drug Administration panel decided not to recommend CardioMEMS implantable heart device for treating heart failure because supporting clinical research appeared biased by human intervention.Six out of 10 members of the FDA advisory committee of outside ...
NEW YORK (Reuters Health) - In a new study from a single California community, women who had been pregnant at least four times were less likely to die from cardiovascular disease than those who'd never been expecting.Researchers said that could be due ...
NEW YORK (Reuters Health) - A quick transfer from one hospital to another with more sophisticated facilities can be a lifesaver for heart attack patients -- but quick transfers are a rarity in the U.S., researchers said Monday.In a nationwide study published ...
NEW YORK (Reuters Health) - One out of every 10 people who get a stent inserted to open up blocked arteries ends up back in the hospital within 30 days, suggests a new study that also found the readmitted patients are more ...
NEW YORK (Reuters Health) - When an elderly person's chronic disease is impossible to cure, many doctors might assume that patient would chose to improve the quality of his or her remaining life rather than to extend it as is. Those doctors ...
NEW YORK (Reuters Health) - A new analysis of half a million heart attack patients found that people with the warning signs of heart disease -- such as high blood pressure and cholesterol -- are more likely to survive their hospital stay ...
ORLANDO, Fla (Reuters) - A stem cell therapy for treating patients experiencing moderate to severe heart failure showed real promise in preventing serious consequences or death, according to data from a small mid-stage clinical trial.The treatment from Australia's Mesoblast Ltd, known as ...
